AstraZeneca

AstraZeneca Teams Up With Startup Quell in Type 1 Diabetes, IBD Cell Therapy Pact
AstraZeneca Teams Up With Startup Quell in Type 1 Diabetes, IBD Cell Therapy Pact
MedCity News
AstraZeneca
Quell Therapeutics
type 1 diabetes
IBD
cell therapy
Flag link:
AstraZeneca, Merck's Lynparza picks up new NICE recommendation
AstraZeneca, Merck's Lynparza picks up new NICE recommendation
Fierce Pharma
AstraZeneca
Merck
Lynparza
NICE
UK
ovarian cancer
fallopian tube cancer
Flag link:
EHA 2023 – Astrazeneca keeps up its complement defense
EHA 2023 – Astrazeneca keeps up its complement defense
EP Vantage
EHA
AstraZeneca
Alexion
Soliris
Ultomiris
Novartis
iptacopan
PNH
Flag link:
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
Stat
AstraZeneca
RSV
FDA
monoclonal antibodies
pediatric
Beyfortus
Flag link:
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
ASCO 2023
oncologists
cancer
AstraZeneca
Tagrisso
non-small cell lung cancer
Novartis
Kisqali
breast cancer
Merck
Keytruda
Moderna Therapeutics
cancer vaccine
Flag link:
FDA sets the stage for adcomm on Sanofi, AZ's RSV prospect later this week
FDA sets the stage for adcomm on Sanofi, AZ's RSV prospect later this week
Fierce Pharma
Sanofi
AstraZeneca
GSK
Pfizer
RSV
vaccines
FDA
Flag link:
ASCO 2023 – early first-line lung cancer data mined for datopotamab gold
ASCO 2023 – early first-line lung cancer data mined for datopotamab gold
EP Vantage
ASCO 2023
Daiichi Sankyo
AstraZeneca
datopotamab deruxtecan
non-small cell lung cancer
Flag link:
ASCO 2023: AstraZeneca’s PD-1/TIGIT shows promise in checkpoint-exposed NSCLC
ASCO 2023: AstraZeneca’s PD-1/TIGIT shows promise in checkpoint-exposed NSCLC
Clinical Trials Arena
ASCO 2023
AstraZeneca
clinical trials
non-small cell lung cancer
rilvegostomig
Flag link:
ASCO: AstraZeneca Posts Strong Survival Data for Tagrisso in NSCLC Patients
ASCO: AstraZeneca Posts Strong Survival Data for Tagrisso in NSCLC Patients
BioSpace
ASCO 2023
AstraZeneca
Tagrisso
non-small cell lung cancer
Flag link:
AZ notches postmarket win for bleeding reversal agent Andexxa, plans to seek full approval
AZ notches postmarket win for bleeding reversal agent Andexxa, plans to seek full approval
Fierce Pharma
AstraZeneca
bleeding reversal
AndexXa
Flag link:
AstraZeneca study points to new uses for targeted cancer drug Enhertu
AstraZeneca study points to new uses for targeted cancer drug Enhertu
BioPharma Dive
ASCO 2023
AstraZeneca
Enhertu
uterine cancer
cervical cancer
ovarian cancer
bladder cancer
Flag link:
ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?
ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?
Fierce Pharma
ASCO 2023
AstraZeneca
Lynparza
Imfinzi
ovarian cancer
Flag link:
FDA clears narrow use of Lynparza in prostate cancer, continuing ‘shift’ on PARP drugs
FDA clears narrow use of Lynparza in prostate cancer, continuing ‘shift’ on PARP drugs
BioPharma Dive
AstraZeneca
Merck
Lynparza
prostate cancer
FDA
Flag link:
Liberate Bio taps former AZ drug-delivery head for CEO post
Liberate Bio taps former AZ drug-delivery head for CEO post
Medical Marketing and Media
Liberate Bio
Pharma CEOs
AstraZeneca
Shawn Davis
Flag link:
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
AstraZeneca
IBD
AbbVie
JNJ
brazikumab
Skyrizi
Stelara
Flag link:
Go or no go? Key FDA decisions for Argenx and Regeneron
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Flag link:
AstraZeneca reports positive results from endometrial cancer therapy trial
AstraZeneca reports positive results from endometrial cancer therapy trial
Clinical Trials Arena
AstraZeneca
endometrial cancer
clinical trials
Imfinzi
Lynparza
Flag link:
AstraZeneca's drug combo shows positive results in late-stage cancer trial
AstraZeneca's drug combo shows positive results in late-stage cancer trial
Reuters
ASCO 2023
AstraZeneca
Imfinzi
Lynparza
endometrial cancer
Flag link:
AstraZeneca Deepens Gene Editing Capabilities with Revvity Partnership
AstraZeneca Deepens Gene Editing Capabilities with Revvity Partnership
BioSpace
AstraZeneca
Revvity
gene editing
cell therapy
Flag link:
AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial
AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial
Yahoo/Reuters
AstraZeneca
clinical trials
Tagrisso
Flag link:

Pages